Mother Infant Research Institute at Tufts Medical Center, Boston, Massachusetts.
Tufts Clinical and Translational Science Institute, Boston, Massachusetts.
Clin Ther. 2018 Feb;40(2):345-348. doi: 10.1016/j.clinthera.2018.01.004. Epub 2018 Jan 19.
The ability of sophisticated sensors and medical devices to monitor critical biomarkers has the potential to greatly advance precision medicine initiatives. A stakeholder event was organized to develop working models for the evolution of the field.
A workshop devoted to the subject matter was held at the Tufts Clinical and Translational Science Institute involving clinicians, device developers, regulators, engineers, and scientists.
Several areas for collaborative development were identified and interested teams offered resources for development of research programs.
The diversity of relevant stakeholders presents a major opportunity and challenge in translational research. It is evident that the CTSI national network can take a leadership role in the rapidly advancing and potentially transformative field of digital biomarkers.
精密传感器和医疗设备监测关键生物标志物的能力，有可能极大地推动精准医疗计划。为此，组织了一次利益攸关方活动，以制定该领域发展的工作模式。
在塔夫茨临床与转化科学研究所举办了一次专门讨论该主题的研讨会，参与者包括临床医生、设备开发商、监管机构、工程师和科学家。
确定了几个合作开发领域，有兴趣的团队为研究计划的开发提供了资源。
相关利益攸关方的多样性在转化研究中既是一个重大机遇，也是一个挑战。显然，CTSI 国家网络可以在数字生物标志物这一快速发展且具有潜在变革性的领域发挥领导作用。
